Madrigal Pharmaceuticals, Inc. (MDGL)

528.91 +1.22 (+0.23%) USD  |  NASDAQ  |  Apr 22, 15:06
More

Madrigal Pharmaceuticals Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Insmed, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Eli Lilly & Co. Upgrade
PTC Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade